AAAdam Alexandersson

Adam Alexandersson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam Alexandersson has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Longitudinal Plasma Proteomics Distinguishes Primary Immune Tolerance from Chronic Graft-versus-Host Disease After Pediatric allo-HSCT

    by Daehong Kim, Yaxin Jing, Elli Äärimaa, Erkka Järvinen, Heljä Lång, Adam Alexandersson, Samppa Ryhänen, Minna Koskenvuo, Markku Varjosalo, Eliisa Kekäläinen

    Chronic graft-versus-host disease (cGvHD) remains a major cause of morbidity after pediatric allogeneic hematopoietic stem cell transplantation (HSCT), but the early plasma molecular features associated with primary immune tolerance (PIT) versus cGvHD are incompletely understood. We performed longitudinal LC-MS plasma proteomics in 32 pediatric allo-HSCT recipients sampled at Months 1, 3, 6, 9, and 12 after transplantation, quantifying 4,702 proteins. Across timepoint-specific differential-abundance analyses, Month 3 showed the strongest observed PIT-cGvHD proteomic separation and was selected for deeper exploratory characterization. At Month 3, eight proteins were higher in PIT at BH-FDR <0.05, including the 19S proteasome ATPases PSMC1, PSMC3 and PSMC5, the chaperonin subunit CCT3, the ubiquitin-conjugating enzyme UBE2O, and APEH, RAN and NME1, pointing to differences in protein degradation and folding pathways. Time-resolved pathway analysis showed PIT-associated immune, immunoglobulin, and proteostasis programs at distinct post-transplant intervals, whereas Month-3 cGvHD-associated profiles were enriched for platelet activation, cell adhesion, transmembrane transport, and metabolic processes. Outcome-blinded clustering of the 500 most temporally variable proteins resolved three descriptive trajectory patterns: a transient Month-3 peak, a Month-3 nadir with late recovery, and an early-high/late-decline pattern. The distribution of Month-3 PIT–cGvHD protein effects differed across outcome-blinded trajectory clusters, providing an internally consistent temporal framework for the Month-3 signal. These exploratory findings nominate Month 3 as a potentially informative interval of molecular divergence after pediatric allo-HSCT and identify pathway-level features of PIT and cGvHD for prospective validation.

  • Open Access

    Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation

    by Adam Alexandersson, Mikko S Venäläinen, Nelli Heikkilä, Xiaobo Huang, Mervi Taskinen, Pasi Huttunen, Laura L Elo, Minna Koskenvuo, Eliisa Kekäläinen

    We studied the associations between inflammation‐related proteins in circulation and complications after pediatric allogenic hematopoietic stem cell transplantation (HSCT), to reveal proteomic signatures or individual soluble proteins associated with specific complications after HSCT. We used a proteomics method called Proximity Extension Assay to repeatedly measure 180 different proteins together with clinical variables, cellular immune reconstitution and blood viral copy numbers in 27 children (1–18 years of age) during a 2‐year follow‐up after allogenic HSCT. Protein profile analysis was performed using unsupervised hierarchical clustering and a regression‐based method, while the Bonferroni‐corrected Mann–Whitney U‐test was used for time point–specific comparison of individual proteins against outcome. At 6 months after allogenic HSCT, we could identify a protein profile pattern associated with occurrence of the complications such as chronic graft‐versus‐host disease, viral infections, relapse and death. When protein markers were analyzed separately, the plasma concentration of the inhibitory and cytotoxic T‐cell surface protein FCRL6 (Fc receptor‐like 6) was higher in patients with cytomegalovirus (CMV) viremia [log2‐fold change 1.5 (P = 0.00099), 2.5 (P = 0.00035) and 2.2 (P = 0.045) at time points 6, 12 and 24 months]. Flow cytometry confirmed that FCRL6 expression was higher in innate‐like γδ T cells, indicating that these cells are involved in controlling CMV reactivation in HSCT recipients. In conclusion, the potentially druggable FCRL6 receptor on cytotoxic T cells appears to have a role in controlling CMV viremia after HSCT. Furthermore, our results suggest that system‐level analysis is a useful addition to the studying of single biomarkers in allogenic HSCT.


  • Open Access

    Proteomics screening post pediatric allogeneic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and CMV reactivation

    by Adam Alexandersson, Mikko S Venäläinen, Nelli Heikkilä, Xiaobo Huang, Mervi Taskinen, Pasi Huttunen, Laura L Elo, Minna Koskenvuo, Eliisa Kekäläinen

    Objective: To study kinetics and associations between inflammation related proteins in circulation after pediatric allogenic hematopoietic stem cell transplantation (HSCT) to reveal proteomic signatures or individual soluble proteins associated with specific complications post HSCT. Methods: We used a proteomics method called Proximity Extension Assay to repeatedly measure 180 different proteins together with clinical variables, cellular immune reconstitution, and blood viral copy numbers in 27 children aged 1-18 years during a two-year follow up after allogenic HSCT. Protein profile analysis was done using unsupervised hierarchical clustering and a regression-based method, while Bonferroni-corrected Mann-Whitney U test was used for time point specific comparison of individual proteins against outcome. Results: At 6 months after allogenic HSCT, we could identify a protein profile pattern associated with occurrence of the complications chronic graft-versus-host disease, viral infections, relapse, and death. When protein markers were analyzed separately, the plasma concentration of the inhibitory and cytotoxic T cell surface protein FCRL6 (Fc receptor-like 6) was higher in patients with CMV viremia (log2-fold change 1.5 (p0.00099), 2.5 (p=0.00035) and 2.2 (p=0.045) at time points 6, 12 and 24 months). Flow cytometry confirmed that FCRL6 expression was higher in innate-like γδ T cells, indicating that these cells have a role in controlling CMV reactivation in HSCT recipients. Conclusions: The potentially druggable FCRL6 receptor on cytotoxic T cells appears to have a role in controlling CMV viremia post-HSCT. Our results suggest that system level analysis is a useful addition to the studying of single biomarkers in allogeneic HSCT.


  • Respiratory viruses after paediatric allogenic haematopoietic stem cell transplantation

    by Elli-Maija Ukonmaanaho, Adam Alexandersson, Laura Mannonen, Irmeli Lautenschlager, Mervi Taskinen, Minna Koskenvuo


  • Open Access

    Decreased airway epithelial ion transport was associated with the severity of the respiratory syncytial virus infection and complications in infants

    by Anu Kaskinen, Adam Alexandersson, Sture Andersson, Harri Saxén, Ville Peltola, Kaija‐Leena Kolho, Otto Helve

    The respiratory syncytial virus (RSV) primarily infects airway epithelial cells. It also decreases airway epithelial sodium transport, especially through the epithelial sodium channel (ENaC) (1), which is crucial for osmosis‐based fluid absorption across respiratory epithelium. Meanwhile, the electrochemical balance is maintained by secretion of chloride ions through apical chloride channels, including the cystic fibrosis transmembrane conductance regulator (CFTR) (1). In animals, ENaC inhibition has caused middle ear fluid collection in acute otitis media (AOM) (2).


  • Viral infections and immune reconstitution interaction after pediatric allogenic hematopoietic stem cell transplantation

    by Adam Alexandersson, Minna Koskenvuo, Anette Tiderman, Mitja Lääperi, Pasi Huttunen, Ulla Saarinen-Pihkala, Veli-Jukka Anttila, Irmeli Lautenschlager, Mervi Taskinen

    Background: Viral infections are a major cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Although immune suppression plays a central role, the literature shows conflicting results on interplay between post-transplant immune reconstitution (IR) and viral infections. Methods: We prospectively studied viral infections and IR in 30 pediatric patients undergoing allogenic HSCT, with a follow-up time of 24 months. In total, 1337 blood (CMV, EBV, HHV-6, ADV and BKV) and urine (BKV and JCV) virus samples were analyzed. IR including B-cells (CD19+), T cells (CD3+, CD4+, CD8+) and NK-cells were measured. Clinical outcomes included overall survival (OS), non-relapse mortality (NRM), graft-versus-host disease (GVHD) and occurrence of blood culture positive bacterial infections. Results: We found BKV reactivation to be most frequent, 47% of the children had viremia and 77% viruria. The frequencies of CMV, HHV-6 and adeno viremia were 37%, 37% and 6%, respectively. Viremias beyond 3 months post-HSCT were uncommon. Factors such as GVHD, use of steroids, EBV and CMV infections and pre-transplant irradiation affected IR. No specific viral infection or IR related factor was associated to OS or NRM. Conclusions: Viral infections and IR interact in a bi-directional manner. Accordingly, close follow-up of both IR and viral loads is warranted.